Funds · AKTS

Who owns AKTS?

Institutional ownership of Aktis Oncology Inc. from Form 13F, Q2 2026

114 institutional managers reported holding Aktis Oncology Inc. (AKTS) in Form 13F filings for Q2 2026, with 34,170,226 shares worth $1.1B. The largest reported holder was MPM Bioimpact LLC. Managers that filed both quarters cut a net 870,460 shares (-2.6%). 51 opened new positions and 6 sold out.

Funds holding
114
Value held
$1.1B
New / sold out
51 / 6
Net shares, same filers
-2.6%

Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

Largest holders of AKTS

FundValueShare of 13F holdingsSharesMove
MPM Bioimpact LLC$156M14.2%4,835,872Unchanged
EcoR1 Capital, LLC$155M14.1%4,824,469Unchanged
Blue Owl Capital Holdings LP$99.0M9.0%3,070,219Trimmed
BlackRock, Inc.$73.4M6.7%2,278,358Added
T. Rowe Price Investment Management, Inc.$66.1M6.0%2,051,447Trimmed
Wellington Management Group LLP$63.4M5.8%1,966,244Trimmed
RTW Investments, LP$51.3M4.7%1,592,043Unchanged
Ra Capital Management, L.p.$42.4M3.8%1,314,405Trimmed
Jupiter Topco LLC$42.4M3.8%1,314,267First report
Baker Bros. Advisors LP$32.1M2.9%996,351Unchanged
Octagon Capital Advisors LP$31.0M2.8%960,847Unchanged
Merck & Co., Inc.$30.7M2.8%952,844Unchanged
Vanguard Capital Management LLC$26.3M2.4%817,075Trimmed
Price T Rowe Associates Inc$24.6M2.2%763,499Trimmed
TCG Crossover Management, LLC$22.5M2.0%696,560New
Geode Capital Management, LLC$16.8M1.5%520,737Added
Eventide Asset Management, LLC$16.3M1.5%507,000Unchanged
Avidity Partners Management LP$15.6M1.4%484,200Trimmed
State Street Corp$15.6M1.4%484,010Added
a16z Capital Management, L.L.C.$13.4M1.2%415,000Unchanged
Alyeska Investment Group, L.P.$9.3M0.8%290,000Unchanged
FMR LLC$9.2M0.8%285,631Trimmed
ArrowMark Colorado Holdings LLC$7.9M0.7%245,872Trimmed
Northern Trust Corp$5.8M0.5%180,575Added
Charles Schwab Investment Management Inc$5.4M0.5%166,842Added

Share of 13F holdings is each fund's shares as a share of the 34,170,226 AKTS shares all 13F filers reported, not of shares outstanding.

The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $64.4M and sold $88.0M; 27 added and 18 trimmed.

Schedule 13D and 13G filings on AKTS

Owners of more than 5% must file within days, so these can be newer than the 13F data.

Questions about AKTS ownership

Who owns AKTS stock?
114 institutional investment managers reported AKTS positions in their Form 13F filings for Q2 2026, holding 34,170,226 shares worth $1.1B in total. MPM Bioimpact LLC reported the largest position.
Are funds buying or selling AKTS?
In Q2 2026, 51 managers opened new AKTS positions, 27 added, 18 trimmed and 6 sold out. Managers that filed in both quarters sold a net 870,460 shares.
How current is this AKTS institutional ownership data?
It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to AKTS by CUSIP. Options are left out. AKTS news and filings · AKTS insider trades · Top funds